Lisdexamfetamine

Summary

Lisdexamfetamine dimesylate is a pharmacologically inactive prodrug. After oral administration, lisdexamfetamine is rapidly absorbed from the gastrointestinal tract and is primarily hydrolysed by red blood cells to dexamfetamine, which is the active ingredient of the drug.

Persistence. It cannot be excluded that dexamfetamine is persistent, due to the lack of data.

Bioaccumulation. It cannot be excluded that dexamfetamine bioaccumulates, due to the lack of data.

Toxicity. It cannot be excluded that dexamfetamine is toxic, due to the lack of data.

Risk. Risk of environmental impact of dexamfetamine cannot be excluded, due to the lack of environmental toxicity data.

Environmental information is missing about lisdexamfetamine and dexamfetamine on fass.se (2024-04-26). It is voluntary for manufacturers to provide information about environmental impact on fass.se.